Assessment of Lipid Peroxidation and Antioxidant Status in a Sample of Prostate Cancer Patients in Bangladesh
Lipid peroxidation and antioxidant in prostate cancer
DOI:
https://doi.org/10.3329/bmrcb.v48i1.60656Keywords:
Prostate cancer, Lipid peroxidation, Antioxidant, MalondialdehydeAbstract
Background: Prostate cancer (PCa) is the second leading cause of cancer-related mortality in men. Oxidative stress has long been implicated in cancer development and progression.
Objective: To evaluate the lipid peroxidation and antioxidant status in a sample of prostate cancer patients in Bangladesh.
Methods: This case-control study included 207 histopathologically confirmed cases of prostate cancer and 200 age-matched healthy controls. After taking informed written consent, preset questioners were filled up, and about 5 ml of venous blood were collected with all aseptic precaution from each study subject for estimation of serum PSA, MDA, GST, SOD and erythrocyte reduced glutathione (GSH). All data were plotted in SPSS version 23, and different statistical analyses were done.
Results: In this study, the mean age of cases was 67.27±8.28 years, and among control, it was 62.17±6.77 years. Oxidative stress marker malondialdehyde was found significantly increased in prostate cancer patients than control. On the other hand, antioxidant erythrocyte reduced glutathione (GSH), and superoxide dismutase (SOD) were significantly reduced, and glutathione S transferase (GST) activity was significantly increased in prostate cancer patients, compared to control group.
Conclusion: This study revealed that overall oxidative stress was increased, and antioxidant levels were impaired in prostate cancer patients, which might play an important role in carcinogenesis. So, screening of oxidative stress and antioxidant status in the elderly male in a regular interval is recommended for early detection and proper management to prevent the aetiopathogenesis of prostate cancer.
Bangladesh Med Res Counc Bull 2022; 48(1): 21-26
Downloads
39
39
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 BMRC
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms.
Authors retain copyright and grant the journal right of first publication.
Articles in the Bangladesh Medical Research Council Bulletin are licensed under a Creative Commons Attribution 4.0 International License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).